MARKET

ROIV

ROIV

Roivant Sciences
NASDAQ
21.79
-0.91
-4.01%
After Hours: 21.65 -0.14 -0.64% 19:44 12/18 EST
OPEN
22.61
PREV CLOSE
22.70
HIGH
22.74
LOW
21.68
VOLUME
8.17M
TURNOVER
--
52 WEEK HIGH
23.47
52 WEEK LOW
8.73
MARKET CAP
15.15B
P/E (TTM)
-39.4461
1D
5D
1M
3M
1Y
5Y
1D
Director Daniel Allen Gold Reports Disposal of Roivant Sciences Ltd. Common Shares
Reuters · 6h ago
Director Keith S. Manchester Reports Disposal of Roivant Sciences Ltd. Common Shares
Reuters · 6h ago
QVT Financial LP Reports Disposal of Roivant Sciences Ltd. Common Shares
Reuters · 6h ago
Roivant Sciences price target raised to $28 from $25 at Guggenheim
TipRanks · 17h ago
Roivant Sciences CEO Matthew Gline Reports Disposal of Common Shares
Reuters · 1d ago
LABU: The Risks And Rewards Of A Leveraged Biotechnology ETF
Seeking Alpha · 1d ago
Roivant Sciences (ROIV): Reassessing Valuation After Bullish Pipeline and Patent Milestone Updates
Simply Wall St · 2d ago
Vivek Ramaswamy Reports Disposal of Roivant Sciences Ltd. Common Shares
Reuters · 3d ago
More
About ROIV
Roivant Sciences Ltd. is a biopharmaceutical company focused on improving the lives of patients by accelerating the development and commercialization of medicines that matter. The Company’s pipeline includes brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis and cutaneous sarcoidosis; IMVT-1402 and batoclimab, fully human monoclonal antibodies targeting FcRn in development across several IgG-mediated autoimmune indications; and mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business.

Webull offers Roivant Sciences Ltd stock information, including NASDAQ: ROIV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ROIV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ROIV stock methods without spending real money on the virtual paper trading platform.